Saji, A. S., Yang, B., Yang, B., Hou, W. T., Liu, X., Ren, Q. P., . . . Yang, X. (2023, January). Combined NK-CIK and PD-1 inhibitor (nivolumab), an effective immunotherapy for treating intrahepatic lymphoepithelioma-like cholangiocarcinoma unassociated with EBV infection: Two case reports and a literature review. Frontiers in Oncology.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Saji, Alen Sam, Biao Yang, Biao Yang, Wan Ting Hou, Xia Liu, Qiu Ping Ren, Yuan Feng Wei, Yu Zu Zhang, و Xi Yang. "Combined NK-CIK and PD-1 Inhibitor (nivolumab), an Effective Immunotherapy for Treating Intrahepatic Lymphoepithelioma-like Cholangiocarcinoma Unassociated with EBV Infection: Two Case Reports and a Literature Review." Frontiers in Oncology Jan. 2023.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Saji, Alen Sam, et al. "Combined NK-CIK and PD-1 Inhibitor (nivolumab), an Effective Immunotherapy for Treating Intrahepatic Lymphoepithelioma-like Cholangiocarcinoma Unassociated with EBV Infection: Two Case Reports and a Literature Review." Frontiers in Oncology, Jan. 2023.